AS ONE (7476) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
31 Jul, 2026Corporate overview
Headquartered in Osaka, established in 1933, with 758 employees and listed on the TSE Prime Market.
Major business is sales of research instruments, nursing, and caring goods for medical institutions.
FY ended March 2026: net sales ¥110.6B, total assets ¥102.4B, net assets ¥71.1B, equity ratio 69.4%.
Business model and market
Provides over 14 million products, including scientific equipment, consumables, and medical supplies, via distributors.
Efficient supply system with 5,500 suppliers and 4,100 distributors, leveraging large-scale logistics centers and a rapid delivery network.
Main sales segments: scientific (63%), industrial (21%), hospital/nursing care (15%).
Addresses market needs for cost, time, and equipment utilization with unique products, rentals, and services.
Japan’s R&D expenditure is approx. ¥24T, with a research product sales market of ¥300B.
Key strengths
Extensive product assortment (14 million items) and strong original/private brand product development (34% sales share).
Industry’s largest product database (SHARE-DB) with real-time inventory visibility.
Diverse promotional media, including catalogs and EC tools, with EC net sales CAGR of 18.6% (2020–2026).
Advanced logistics with five nationwide centers, achieving 95% same-day shipment for catalog items.
Latest events from AS ONE
- Record Q1 sales and profits achieved, with net sales up 17.0% and operating profit up 27.3%.7476
Q1 202731 Jul 2026 - Record sales and profits, robust e-commerce growth, and strong shareholder returns continue.7476
Q4 202613 May 2026 - Strong profit and sales growth driven by e-commerce and industrial segments; outlook steady.7476
Q3 202630 Jan 2026 - Record profit growth and margin gains offset medical sector weakness; profit outlook raised.7476
Q2 202631 Oct 2025 - Strong profit and sales growth driven by scientific and industrial demand; outlook maintained.7476
Q1 202631 Jul 2025 - Record sales and profit growth driven by e-commerce and product expansion.7476
Q2 202513 Jun 2025 - Record sales and profit growth, led by e-commerce, offset by lower gross margin.7476
Q1 202513 Jun 2025 - Record sales, profit, and dividend growth with strong EC momentum and positive outlook.7476
Q4 20256 Jun 2025 - Net sales and profits rose over 10% year-on-year, with robust e-commerce and digital growth.7476
Q3 20255 Jun 2025